Healthwise Centre of Expertise of the University of Groningen and the University Medical Center Groningen will host a symposium relating to the theme ‘Expensive medicines’ on Wednesday, 31 May. Among others, Wouter Bos, Bart Benraad and Alfred Bein will present their view of drug prices on that occasion. Mr Bos is chairman of the VUmc board, Mr Benraad is a programme manager at the Association of Dutch Health Insurers (Zorgverzekeraars Nederland) and Mr Bein is the general director of Novartis Pharmaceutical Company.
Due to the growing knowledge in the field of health and disease control, the world of medicines is making major steps forward. An increasing amount of both new and improved drugs, offering prospects for patients with severe conditions, are put on the market. At the same time, expenditure on medicines in this country has significantly increased because certain groups of medicines come with hefty price tags. This means that the question from society ‘How do we keep medicines expenditure within the budget?’ is a highly topical issue.
At the symposium, a number of prominent speakers from the healthcare sector will draw a comprehensive picture of the issues which our society will be confronted with. Based on their specific skills and expertise, the speakers will furnish a number of solutions to encourage the debate. The impact of politics on the healthcare sector will also be discussed. The aim of the discussion is to provide a frame of reference for solving the issue of too costly medicines.
Those interested are very welcome at this spring symposium, which will be held in the red hall and the blue patio at UMCG from noon till 5 p.m. Please sign up via
. The entrance fee is €75.00.
Healthwise is one of eleven centres of expertise set up by the Faculty of Economics and Business of the University of Groningen. Healthwise connects scientific knowledge with questions from practice by conducting multi-disciplinary research within the healthcare sector. Experienced researchers and students provide research which is customized to the needs of various organisations and based on both social and business questions. Healthwise's applied research ties in with the latest developments in society and focusses on translating fundamental knowledge into healthcare practice, both now and in the future. By sharing knowledge, the researchers and professionals linked to Healthwise want to make a contribution to guaranteeing the future of the healthcare sector.
Contact: Isabella Bazuin
NB: Please note that this event is in Dutch
> More news from the Faculty of Economics and Business
> FEB experts in the media
Households that own their own home paid 776 euros to the municipality on average this year, which is 5.0 percent more than last year. 295 euros of this amount covers the immovable property tax (ozb), 283 euros are paid for waste collection levy, and...
Een panel van zes economen en marketeers van de Faculteit Economie en Bedrijfskunde van de Rijksuniversiteit Groningen bespreekt in een actuele 'podcast' op YouTube de gevolgen van het coronavirus voor de Nederlandse en Europese economie, de internationale...
The UK’s Department for International Development has awarded a large-scale multi-year research grant to a consortium of renowned researchers, with the GGDC as one of the core partners.